The aim of this study was to evaluate the safety and effectiveness of erlotinib plus DC/CIK in
maintenance therapy of advanced non–small cell lung cancer. After 4 cycles of the 2-drug …

The aim of this study was to determine the efficacy and toxicity of pemetrexed plus dendritic
cells (DCs) in patients suffering from stage IIIB or IV lung adenocarcinoma, who had …

Aims and background The incidence and development of cancer are closely related to
dysfunction of immune function. The immune system cannot identify and remove malignant …

Background Lung cancer is the leading cause for cancer-related mortality and morbidity,
and the survival of late-stage non-small cell lung cancer (NSCLC) remains poor. We hereby …

Background Lung cancer, particularly non-small-cell lung cancer (NSCLC) is the leading
cause of cancer mortality. Chemotherapy combined dendritic cells co-cultured with cytokine …

Background: Non-small-cell lung cancer (NSCLC) is one of the most fatal cancers, which
leads to large number of people dead. Followed by surgery, chemotherapy and …

Dendritic cells co-cultured with cytokine-induced killer cells (DC-CIK) immunotherapy has
been widely studied and might be a new therapeutic strategy for non-small-cell lung cancer …

Background Advanced non-small cell lung cancer (NSCLC) has remained challenging to
treat effectively. This study aimed to investigate the clinical effects and safety of …

Objective The aim of the study was to evaluate the safety and therapeutic effects of
autologous dendritic cells co-cultured with cytokine-induced killer cells (DC-CIK) combined …

Dendritic cells (DC) play a crucial role in the induction of an effective antitumor immune
response. Cytokine-induced killer (CIK) cells, a subset of T lymphocytes, have the capacity …